In vitro and in vivo comparative study of the phototherapy anticancer activity of hyaluronic acid-modified single-walled carbon nanotubes, graphene oxide, and fullerene
Source abstract
Abstract
In this work, carbon nanomaterials, single-walled carbon nanotubes (SWNT), graphene oxide (GO), and fullerene (C60) were modified by hyaluronic acid (HA) to obtain water-soluble and biocompatible nanomaterials with high tumor-targeting capacity and then the comparative study of these hyaluronic acid-modified carbon nanomaterials was made in vitro and in vivo. The conjugates of hyaluronic acid and carbon nanomaterials, namely, HA-SWNT, HA-GO, HA-C60, were confirmed by UV/Vis spectrum, Fourier transform infrared spectroscopy (FTIR), and a transmission electron microscope (TEM). After HA modification, the sizes of HA-SWNT, HA-GO, and HA-C60 were in a range of 70 to 300 nm, and all the three HA-modified materials were at negative potential, demonstrating that HA modification was in favor of extravasation of carbon materials into a tumor site due to enhanced permeability and retention effect of tumor. Photothermal conversion in vitro test demonstrated excellent photothermal sensitivity of HA-SWNT and HA-GO. But the reactive oxygen yield of HA-C60 was the highest compared with the others under visible light irradiation, which proved the good photodynamic therapy effect of HA-C60. In addition, cytotoxicity experiments exhibited that the inhibitory efficacy of HA-SWNT was the lowest, the second was HA-C60, and the highest was HA-GO, which was consistent with the uptake degree of them. While under the laser irradiation, the cell inhibition of the HA-SWNT was the highest, the second was HA-GO, and the last was HA-C60. In vivo evaluation of the three targeting carbon nanomaterials was consistent with the cytotoxicity assay results. Taken together, the results demonstrated that HA-SWNT and HA-GO were suited for photothermal therapy (PTT) agents for their good photothermal property, while HA-C60 was used as a kind of photodynamic therapy (PDT) agent for its photodynamic effect.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications · Fullerene Chemistry and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Afreen S, Muthoosamy K, Manickam S et al (2015) Functionalized fullerene (C60) as a potential nanomediator in the fabrication of highly sensitive biosensors. Biosens Bioelectron 63:354–36410.1016/j.bios.2014.07.044 ↗
2. Assanhou AG, Li WY, Zhang L et al (2015) Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Biomaterials 73:284–22910.1016/j.biomaterials.2015.09.022 ↗
3. Bhana S, O’Connor R, Johnson J et al (2016) Photosensitizer-loaded gold nanorods for near infrared photodynamic and photothermal cancer therapy. J Colloid Interface Sci 469:8–1610.1016/j.jcis.2016.02.012 ↗
4. Cao XY, Tao L, Wen SH et al (2015) Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells. Carbohydr Res 405:70–7710.1016/j.carres.2014.06.030 ↗
5. Chauhan G, Chopra V, Tyagi A et al (2017) “Gold nanoparticles composite-folic acid conjugated graphene oxide nanohybrids” for targeted chemo-thermal cancer ablation: in vitro screening and in vivo studies. Eur J Pharm Sci 96:351–36110.1016/j.ejps.2016.10.011 ↗
6. Chen JQ, Liu HY, Zhao CB et al (2014) One-step reduction and PEGylation of graphene oxide for photothermally controlled drug delivery. Biomaterials 35:4986–499510.1016/j.biomaterials.2014.02.032 ↗
7. Choi KY, Min KH, Yoon HY et al (2011a) PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials 32:1880–188910.1016/j.biomaterials.2010.11.010 ↗
8. Choi WI, Kim J-Y, Kang C et al (2011b) Tumor regression in vivo by photothermal therapy based on gold-nanorod-loaded functional nanocarriers. ACS Nano 5:1995–200310.1021/nn103047r ↗
9. Datir SR, Das M, Singh RP et al (2012) Hyaluronate tethered, “smart” multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin. Bioconjug Chem 23:2201–221310.1021/bc300248t ↗
10. Deni E, Zamarrón A, Bonaccorsi P et al (2016) Glucose-functionalized amino-OPEs as biocompatible photosensitizers in PDT. Eur J Med Chem 111:58–7110.1016/j.ejmech.2016.01.041 ↗
11. Feng QH, Zhang YY, Zhang WX et al (2016) Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography. Acta Biomater 38:129–14210.1016/j.actbio.2016.04.024 ↗
12. Hou L, Feng QH, Wang YT et al (2015) Multifunctional nanosheets based on hyaluronic acid modified graphene oxide for tumor-targeting chemophotothermal therapy. J Nanopart Res 17:162–17810.1007/s11051-015-2966-9 ↗
13. Kim S, Lee DJ, Kwag DS et al (2014) Acid pH-activated glycol chitosan/fullerene nanogels for efficient tumor therapy. Carbohydr Polym 101:692–69810.1016/j.carbpol.2013.09.108 ↗
14. Kwag DS, Park K, Oh KT et al (2012) Hyaluronated fullerenes with photoluminescent and antitumoral activity. Chem Commun 49:282–28410.1039/C2CC36596K ↗
15. Lee J-Y, Termsarasab U, Park J-H et al (2016) Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery. J Control Release 236:38–4610.1016/j.jconrel.2016.06.021 ↗
16. Li J, Huo MR, Wang J et al (2012) Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Biomaterials 33:2310–232010.1016/j.biomaterials.2011.11.022 ↗
17. Li Q, Hong L, Li HG et al (2017) Graphene oxide-fullerene C60 (GO-C60) hybrid for photodynamic and photothermal therapy triggered by near-infrared light. Biosens Bioelectron 89:477–48210.1016/j.bios.2016.03.072 ↗
18. Li WH, Yi XL, Liu X et al (2016) Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. J Control Release 225:170–18210.1016/j.jconrel.2016.01.049 ↗
19. Li WM, Su CW, Chen YW et al (2015) In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs. Acta Biomater 15:191–19910.1016/j.actbio.2014.12.013 ↗
20. Liang XY, Shang WT, Chi CW et al (2016) Dye-conjugated single-walled carbon nanotubes induce photothermal therapy under the guidance of near-infrared imaging. Cancer Lett 383:243–24910.1016/j.canlet.2016.09.006 ↗
21. Lin CW, Lu KY, Wang SY et al (2016) CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release. Acta Biomater 35:280–29210.1016/j.actbio.2016.02.005 ↗
22. Lin WJ, Lee WC, Shieh MJ (2017) Hyaluronic acid conjugated micelles possessing CD44 targeting potential for gene delivery. Carbohydr Polym 155:101–10810.1016/j.carbpol.2016.08.021 ↗
23. Miao WJ, Shim G, Lee S et al (2014) Structure-dependent photothermal anticancer effects of carbon-based photoresponsive nanomaterials. Biomaterials 35:4058–406510.1016/j.biomaterials.2014.01.043 ↗
24. Neelgund GM, Oki AR (2016) Influence of carbon nanotubes and graphene nanosheets on photothermal effect of hydroxyapatite. J Colloid Interface Sci 484:135–14510.1016/j.jcis.2016.07.078 ↗
25. Riehemann K, Schneider SW, Luger TA et al (2009) Nanomedicine-challenge and perspectives. Angew Chem Int Ed Engl 48:872–89710.1002/anie.200802585 ↗
26. Sahu A, Choi WI, Lee JH et al (2013) Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials 34:6239–624810.1016/j.biomaterials.2013.04.066 ↗
27. Shams M, Owczarczak B, Manderscheid-Kern P (2015) Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary disease. Cancer Immunol Immunother 64:287–29710.1007/s00262-014-1633-9 ↗
28. Sheng ZH, Song L, Zheng JX et al (2013) Protein-assisted fabrication of nano-reduced graphene oxide for combined in vivo photoacoustic imaging and photothermal therapy. Biomaterials 34:5236–524310.1016/j.biomaterials.2013.03.090 ↗
29. Shi JJ, Wang BH, Wang L et al (2016) Fullerene (C60)-based tumor-targeting nanoparticles with “off-on” state for enhanced treatment of cancer. J Control Release 235:245–25810.1016/j.jconrel.2016.06.010 ↗
30. Tian B, Wang C, Zhang S (2011) Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano 5:7000–700910.1021/nn201560b ↗
31. Veiseh M, Breadner D, Ma J et al (2012) Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes. Biomacromolecules 13:12–2210.1021/bm201143c ↗
32. Wang AT, Liang DS, Liu YJ et al (2015) Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors. Biomaterials 53:160–17210.1016/j.biomaterials.2015.02.077 ↗
33. Wong BS, Yoong SL, Jagusiak A et al (2013) Carbon nanotubes for delivery of small molecule drugs. Adv Drug Deliv Rev 65:1964–201510.1016/j.addr.2013.08.005 ↗
34. Yang DZ, Feng LZ, Dougherty CA et al (2016) In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide. Biomaterials 104:361–37110.1016/j.biomaterials.2016.07.029 ↗
35. Zhang HJ, Hou L, Jiao XJ et al (2015) Transferrin-mediated fullerenes nanoparticles as Fe2+-dependent drug vehicles for synergistic anti-tumor efficacy. Biomaterials 37:353–36610.1016/j.biomaterials.2014.10.031 ↗
36. Zhang YF, He LY, Wu J et al (2016) Switchable PDT for reducing skin photosensitization by a NIR dye inducing self-assembled and photo-disassembled nanoparticles. Biomaterials 107:23–3210.1016/j.biomaterials.2016.08.037 ↗
37. Zhou MJ, Zhang XJ, Yang YL et al (2013) Carrier-free functionalized multidrug nanorods for synergistic cancer therapy. Biomaterials 34:8960–896710.1016/j.biomaterials.2013.07.080 ↗